View More Recent Stories

Dec 18, 2024 08:02AM Krystal Biotech (KRYS) Announces Early Evidence of Monotherapy Activity in Heavily Pre-Treated Patients with Advanced Non-Small Cell Lung Cancer
Dec 12, 2024 12:53PM BofA Securities Reiterates Buy Rating on Krystal Biotech (KRYS)
Dec 9, 2024 04:16PM Krystal Biotech (KRYS) Provides Update on EMA’s Ongoing Regulatory Review of B-VEC for Dystrophic Epidermolysis Bullosa
Nov 4, 2024 04:42PM Krystal Biotech (KRYS) PT Raised to $206 at Citi
Nov 4, 2024 08:02AM Krystal Biotech, Inc. (KRYS) Misses Q3 EPS by 8c
Oct 1, 2024 06:56AM Stifel Reiterates Buy Rating on Krystal Biotech (KRYS)
Aug 30, 2024 07:59AM TD Cowen Reiterates Buy Rating on Krystal Biotech (KRYS)
Aug 29, 2024 06:42AM Krystal Biotech (KRYS) PT Raised to $221 at H.C. Wainwright
Aug 28, 2024 09:40AM Stifel Reiterates Buy Rating on Krystal Biotech (KRYS)
Aug 28, 2024 07:01AM Krystal Biotech's (KRYS) Jeune Aesthetics Announces Phase 1 Positive Interim Safety and Efficacy Results for KB301
Aug 5, 2024 08:02AM Krystal Biotech, Inc. (KRYS) Misses Q2 EPS by 25c Provides Outlook
View More Recent Stories